Related Experiment Video
Updated: May 14, 2026
09:00
Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Published on: April 5, 2017
Leukocyte trafficking mechanisms in epilepsy
Paolo F Fabene1, Carlo Laudanna, Gabriela Constantin
1Department of Neurological, Neuropsychological, Morphological and Movement Sciences, Section of Anatomy, University of Verona, Verona, Italy. paolo.fabene@univr.it
Molecular Immunology
|January 29, 2013
Summary
Leukocyte trafficking, or the movement of white blood cells, plays a critical role in epilepsy and seizures. Therapies targeting leukocyte adhesion show promise for treating and preventing epilepsy.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Epilepsy affects 1% of the global population, characterized by recurrent seizures due to abnormal neuronal activity.
- Current epilepsy treatments focus on neuronal activity but do not address underlying inflammatory mechanisms.
- Emerging evidence suggests inflammation and vascular changes contribute to epilepsy pathogenesis.
Purpose of the Study:
- To investigate the role of leukocyte trafficking in seizure generation.
- To evaluate the therapeutic potential of anti-leukocyte adhesion therapy in epilepsy.
Main Methods:
- Utilized an experimental model of human epilepsy.
- Administered anti-leukocyte adhesion therapy.
- Examined leukocyte accumulation in the brain parenchyma of epilepsy patients.
Main Results:
- Anti-leukocyte adhesion therapy demonstrated therapeutic and preventative effects in an epilepsy model.
- Leukocytes were observed to accumulate in the brain parenchyma of human epilepsy patients.
- Clinical observations suggest therapies targeting leukocyte trafficking may benefit epilepsy patients.
Conclusions:
- Leukocyte trafficking and adhesion mechanisms are integral to seizure generation.
- Targeting leukocyte adhesion offers a novel therapeutic strategy for epilepsy.
- Understanding these mechanisms provides insight into epilepsy-related brain damage.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...